The CD147‐HYALURONAN Axis in Cancer

Abstract

CD147 (basigin; EMMPRIN), hyaluronan, and hyaluronan receptors (e.g., CD44) are intimately involved in several phenomena that underlie malignancy. A major avenue whereby they influence tumor progression is most likely their role in the characteristics of cancer stem cells (CSCs), subpopulations of tumor cells that exhibit chemoresistance, invasiveness, and potent tumorigenicity. Both CD147 and hyaluronan have been strongly implicated in chemoresistance and invasiveness, and may be drivers of CSC characteristics, since current evidence indicates that both are involved in epithelial-mesenchymal transition, a crucial process in the acquisition of CSC properties. Hyaluronan is a prominent constituent of the tumor microenvironment whose interactions with cell surface receptors influence several signaling pathways that lead to chemoresistance and invasiveness. CD147 is an integral plasma membrane glycoprotein of the Ig superfamily and cofactor in assembly and activity of monocarboxylate transporters (MCTs). CD147 stimulates hyaluronan synthesis and interaction of hyaluronan with its receptors, in particular CD44 and LYVE-1, which in turn result in activation of multiprotein complexes containing members of the membrane-type matrix metalloproteinase, receptor tyrosine kinase, ABC drug transporter, or MCT families within lipid raft domains. Multivalent hyaluronan-receptor interactions are essential for formation or stabilization of these lipid raft complexes and for downstream signaling pathways or transporter activities. We conclude that stimulation of hyaluronan-receptor interactions by CD147 and the consequent activities of these complexes may be critical to the properties of CSCs and their role in malignancy. Anat Rec, 303:1573Rec, 303: -1583Rec, 303: , 2020

CD147 as a Target for COVID-19 Treatment: Suggested Effects of Azithromycin and Stem Cell Engagement

“…Expression levels of CD147 and MMPs are often increased in inflammatory processes and tumors and are associated with cancer progression [14]. Cancer stem cells characterized by high cell surface CD147 expression produce more hyaluronan, resulting in stabilization of lipid rafts, as well as reveal enhanced MMP and ABC drug transporter expression, resistance and survival [15]. Recent studies have shown that patients with severe asthma have high levels of MMP-9 in sputum [16], and influenza A virus infection increases CD147 expression in cells from asthmatics [17].…”

Hyaluronan Functions in Wound Repair That Are Captured to Fuel Breast Cancer Progression

“…To date, characterized HA receptors include CD44 [ 56 ], RHAMM (HMMR) [ 23 ], LYVE1 [ 57 ], TLR2/4 [ 29 , 58 ], STAB2/HARE [ 59 ], and LAYN [ 49 ]. CD44, LYVE1, and STAB2/HARE bind to HA via link modules [ 56 , 60 ].…”

A Complex and Evolutive Character: Two Face Aspects of ECM in Tumor Progression

“…High expression of CD44 in cancer cells is also associated with cancer stem cell (CSC) properties and is used as a CSC marker. CD44 + cancer cells show an increase in EMT and in invasion, correlated with poor prognosis ( 55 – 58 ).…”